As of April 2024 SIGA Technologies has a market cap of $0.62 Billion. This makes SIGA Technologies the world's 5719th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.62 B | 55.8% |
2023 | $0.39 B | -25.93% |
2022 | $0.53 B | -3.57% |
2021 | $0.55 B | -0.95% |
2020 | $0.56 B | 45.5% |
2019 | $0.38 B | -39.06% |
2018 | $0.63 B | 65.82% |
2017 | $0.38 B | 144.79% |
2016 | $0.15 B | 587.87% |
2015 | $22.72 M | -70.5% |
2014 | $77.04 M | -55.64% |
2013 | $0.17 B | 28.35% |
2012 | $0.13 B | 4.42% |
2011 | $0.12 B | -81.12% |
2010 | $0.68 B | 174.78% |
2009 | $0.24 B | 116.05% |
2008 | $0.11 B | 10.6% |
2007 | $0.10 B | -16.77% |
2006 | $0.12 B | 398.86% |
2005 | $25.17 M | -38.1% |
2004 | $40.67 M | -4.91% |
2003 | $42.76 M | 131.82% |
2002 | $18.44 M | -37.26% |
2001 | $29.4 M |
On Apr 25th, 2024 the market cap of SIGA Technologies was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | $12.28 B | 1,881.30% | ๐บ๐ธ USA |
Novavax NVAX | $0.57 B | -7.38% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $2.40 B | 288.19% | ๐บ๐ธ USA |
NanoViricides NNVC | $12.95 M | -97.91% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | $0.86 B | 39.42% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $0.10 B | -83.61% | ๐บ๐ธ USA |